Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Multimedia Production

Therapept Explained: Visual Science Series

Short, accessible video explainers translating complex peptide pharmacology into plain English. Below are the complete production packages: presenter scripts, scene-by-scene storyboards, thumbnail concepts, and verified on-site transcripts.

Production Standards: No Synthetic Hype

Pipeline: docs/phase5/VIDEO_PRODUCTION_PLAN.md

Therapept Explained does not publish placeholder videos, fake video players, or automated AI slop. Each episode is authored from peer-reviewed literature with exact shot lists, timing notes, verified citations, and complete on-screen text overlays.

Pilot Episodes in Production (3)

Complete episode packages with scene storyboards, presenter scripts, and full transcripts.

Therapept Explained · Main Cut 3-5 min

What is a peptide?

Scripted · Production Ready

Opening Hook

“You are mostly peptides already — collagen, insulin, every enzyme you own. Here is where the ones in small glass vials come from.”

Viewer Takeaway

A peptide is a short chain of amino acids; the same chemistry that makes your body work can be synthesized, sold, and too often misrepresented.

Thumbnail Art Concept & Visual Assets

Headline: WHAT IS A PEPTIDE?

  • •Split screen: Natural human protein ribbon vs. 15-amino-acid synthetic chain
  • •Clear 3ml glass vial with lyophilized cake labeled 'Amino Acid Sequence'
  • •High-contrast text badge: 'Proteins vs. Peptides'

Color Direction: Deep charcoal (#0D1921) with warm amber and ivory typography

View Shot-by-Shot Storyboard (5 Scenes)Expand ▾
Scene 1 (15s)Overlay: “Amino Acids: The Building Blocks of Life”

Visual: Presenter holds an ordinary apple in one hand and an empty pharmaceutical vial in the other. Warm, editorial studio lighting.

Spoken Audio: “Everything alive is made of amino acids. An apple has them, your muscles have them, and so does this vial. But what turns amino acids into a 'peptide'?”

Asset Spec: Cinematic medium shot of an educator in charcoal clothing holding natural protein source and laboratory glassware, soft natural rim light.

Scene 2 (45s)Overlay: “2–50 Amino Acids = Peptide | 50+ Folded = Protein”

Visual: Animated 2D vector graphic showing 20 individual colored spheres (amino acids) linking together one by one like pearls on a string.

Spoken Audio: “Think of amino acids like individual alphabet letters. When you link two to fifty letters together into a short sentence, you have a peptide. When that sentence stretches into hundreds of letters folded into origami, you have a protein.”

Asset Spec: Clean, minimalist vector diagram showing amino acid pearls connecting with peptide bonds, transforming from linear chain to folded protein.

Scene 3 (60s)Overlay: “Peptides Act as Biological Keys for Cellular Receptors”

Visual: Cutaway diagram of a cell membrane with a receptor pocket. A peptide floats in and fits cleanly into the lock.

Spoken Audio: “Because peptides are short and flexible, they act like precision biological keys. They float through the bloodstream, find a specific lock on a cell surface — called a receptor — and turn on a single cellular function.”

Asset Spec: 3D schematic animation of a ligand binding to a G-protein coupled receptor in a lipid bilayer, charcoal and gold accents.

Scene 4 (50s)Overlay: “Approved Pharmaceuticals vs. Unregulated Research Chemicals”

Visual: Side-by-side comparison: FDA-approved Wegovy prescription pen vs. an unlabeled glass vial from an online vendor.

Spoken Audio: “Here is the critical divide: insulin and Wegovy are peptides approved by regulators and manufactured under strict sterility rules. But the identical chemistry can be synthesized in unregulated chemical labs and sold online with no safety oversight.”

Asset Spec: Clean studio shot comparing prescription packaging with clinical labeling against generic glass vials.

Scene 5 (20s)Overlay: “Therapept: Understand Peptides Without the Hype”

Visual: Presenter on camera pointing to Therapept screen showing compound directory.

Spoken Audio: “That's why Therapept exists: to separate the real chemistry and verified clinical evidence from internet marketing. Every record is indexed at therapept.com.”

View Full Spoken Presenter ScriptExpand ▾
PRESENTER (ON CAMERA): Everything alive is made of amino acids. An apple has them, your muscles have them, and so does this vial. But what turns amino acids into a peptide? GRAPHIC SEQUENCE: Think of amino acids like individual alphabet letters. When you link two to fifty letters together into a short sentence, you have a peptide. When that sentence stretches into hundreds of letters folded into complex origami, you have a full protein. PRESENTER: Because peptides are short, they act like biological keys. When you inject or secrete a peptide, it travels to a specific lock on a cell — called a receptor — and triggers a defined biological action, like telling your pancreas to release insulin or signaling your brain that you are full. COMPARISON: But here is where confusion begins. When that peptide is synthesized in a licensed pharmaceutical plant with sterile verification, it becomes a prescription medicine like semaglutide. When synthesized by unverified overseas chemical suppliers, it is sold as a research chemical with no sterility guarantee. OUTRO: Understand the molecule before you believe the claim. Explore all 32 compounds at Therapept.com.
View Complete On-Site Educational TranscriptExpand ▾

A peptide is a biological polymer consisting of between two and fifty amino acids joined by peptide bonds. Naturally occurring peptides regulate almost every physiological process in the human body, including hormone secretion, appetite signaling, tissue repair, and immune surveillance. Synthetic peptides are created using solid-phase peptide synthesis (SPPS). While approved prescription peptide drugs undergo rigorous clinical testing and sterile compounding oversight, unregulated peptides sold online lack sterility guarantees, regulatory clearance, and verified purity.

Short-Form (Vertical 60s): Collagen vs insulin vs a 'research peptide' in 45 seconds.Topics: amino acids, synthesis, research chemicals, receptors
Therapept Explained · Main Cut 3-5 min

How does retatrutide work?

Scripted · Production Ready

Opening Hook

“In 2023, a single experimental molecule achieved 24% average weight loss in a clinical trial. Here is the three-switch biology behind it.”

Viewer Takeaway

Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors at the same time, reducing appetite while boosting metabolic caloric burn.

Thumbnail Art Concept & Visual Assets

Headline: HOW RETATRUTIDE WORKS

  • •Stylized 3-prong molecular key glowing with three distinct colors (Blue, Violet, Amber)
  • •Highlighted target organs: Brain, Adipose, Liver
  • •Large bold graphic: 'Triple Agonist Explained'

Color Direction: Deep navy charcoal (#0D1921) with Incretin Blue (#2E5A8F) accents

View Shot-by-Shot Storyboard (5 Scenes)Expand ▾
Scene 1 (20s)Overlay: “Retatrutide: The Triple-Agonist Molecule”

Visual: Presenter stands before a three-part anatomical diagram displaying the brain, the pancreas, and the liver.

Spoken Audio: “Most weight-loss medications activate one metabolic hormone receptor. Some activate two. But retatrutide activates three completely different hormone receptors simultaneously.”

Scene 2 (40s)Overlay: “Switch 1: GLP-1 (Appetite & Satiety)”

Visual: Animation zooms into Switch 1: GLP-1 receptor. Food emptying slower from stomach; satiety signals reaching the hypothalamus.

Spoken Audio: “Switch number one is GLP-1. Just like Ozempic, it slows down stomach emptying and tells the appetite centers in your brain that you've had enough to eat.”

Scene 3 (40s)Overlay: “Switch 2: GIP (Fat Metabolism & Nausea Buffer)”

Visual: Animation zooms into Switch 2: GIP receptor on fat cells and brainstem nausea buffering centers.

Spoken Audio: “Switch number two is GIP. This hormone helps fat cells handle nutrients properly, improves insulin sensitivity, and helps buffer against the nausea that GLP-1 often triggers.”

Scene 4 (45s)Overlay: “Switch 3: Glucagon (Energy Expenditure & Liver Fat)”

Visual: Animation zooms into Switch 3: Glucagon receptor on liver cells. Mitochondria burning fatty acids into heat.

Spoken Audio: “Switch number three is the game changer: glucagon. When you diet, your metabolic rate naturally slows down. Glucagon signals the liver to clear out stored fats and boosts energy burn, preventing that metabolic slowdown.”

Scene 5 (35s)Overlay: “NEJM Phase 2 Trial: -24.2% at 48 Weeks”

Visual: Chart showing the NEJM 48-week weight loss curve comparing 12mg (-24.2%) vs placebo (-2.1%).

Spoken Audio: “In its Phase 2 trial of 338 adults, patients on the highest dose lost an average of 24.2% of their body weight over 48 weeks. But it is not approved by the FDA yet, and Phase 3 trials are still running.”

View Full Spoken Presenter ScriptExpand ▾
PRESENTER: Most metabolic drugs turn one biological key. Retatrutide is engineered to turn three separate keys with a single synthetic molecule. SWITCH 1: The first key is GLP-1. It slows stomach motility and tells your hypothalamus to turn down hunger signals. SWITCH 2: The second key is GIP. It enhances insulin sensitivity in fat tissue and helps cushion against digestive nausea. SWITCH 3: The third key is glucagon. Traditionally, dieting lowers resting metabolic rate. Glucagon tells the liver to oxidize stored fats and boosts resting calorie expenditure. CLINICAL TRIAL: In the Phase 2 trial published in the New England Journal of Medicine, participants on the 12 milligram weekly dose achieved an average 24.2% weight reduction over 48 weeks. THE REALITY CHECK: Retatrutide is still an investigational drug. It has not received FDA clearance, and Phase 3 cardiovascular trials are ongoing. Unregulated powders sold online carry severe contamination hazards.
View Complete On-Site Educational TranscriptExpand ▾

Retatrutide (LY3437943) is an investigational unimolecular peptide engineered by Eli Lilly that activates three distinct metabolic hormone receptors: GLP-1, GIP, and glucagon. In Phase 2 clinical trials published in the New England Journal of Medicine (Jastreboff et al., 2023), retatrutide demonstrated unprecedented weight reduction averaging up to 24.2% at 48 weeks in adults with overweight and obesity. Glucagon receptor stimulation offsets the adaptive thermogenesis typically seen during caloric restriction.

Short-Form (Vertical 60s): Why retatrutide turns on three metabolic switches in 60 seconds.Topics: retatrutide, incretins, GLP-1, GIP, glucagon, clinical trials
Therapept Explained · Main Cut 3-5 min

How to evaluate peptide claims online

Scripted · Production Ready

Opening Hook

“The claim has a scientific chart, a doctor on a podcast, and 400,000 views. Here is the 2-minute checklist to tell if it's real.”

Viewer Takeaway

Separating evidence from marketing comes down to four checks: study species, sample size, who funded the claim, and whether an approved drug is being conflated with research chemicals.

Thumbnail Art Concept & Visual Assets

Headline: HOW TO SPOT BOGUS PEPTIDE CLAIMS

  • •A magnifying glass focusing on a Certificate of Analysis (COA)
  • •Checklist graphic with green checks and red flags
  • •Bold text: '4 Tells of Fake Evidence'

Color Direction: Charcoal with gold highlights and red caution badges

View Shot-by-Shot Storyboard (5 Scenes)Expand ▾
Scene 1 (15s)Overlay: “The 2-Minute Peptide Claim Checklist”

Visual: Presenter scrolling on a smartphone displaying hyperbolic social media health claims.

Spoken Audio: “Every day, millions of people hear 'studies show this peptide heals tendons overnight.' But which study? Done on whom? In what dose?”

Scene 2 (45s)Overlay: “Rule 1: In Vitro ≠ Animal ≠ Human Trial”

Visual: Graphic showing a petri dish, a rodent, and a human clinical trial ward.

Spoken Audio: “Check number one: The Species Check. A cell in a dish and a rat in a cage are not a human being. Over 80% of compounds that work in mice fail when tested in human trials.”

Scene 3 (40s)Overlay: “Rule 2: Verify the Source Tier”

Visual: Side-by-side graphic of an academic journal header vs an anonymous forum screenshot.

Spoken Audio: “Check number two: The Source Tier. Does the claim cite a registered clinical trial on ClinicalTrials.gov, or does it cite an anonymous self-experimenter on Reddit?”

Scene 4 (40s)Overlay: “Rule 3: Purity Percentages Require Lot Verification”

Visual: A sample Certificate of Analysis with a red highlight on 'Sample tested: 5mg / Net weight: Unstated'.

Spoken Audio: “Check number three: The Purity Mirage. A piece of paper that says '99% Pure' does not prove what is in the vial unless the laboratory and lot number can be verified independently.”

Scene 5 (30s)Overlay: “Therapept: Independent Science Reference”

Visual: Presenter concludes before the Therapept Evidence Explorer interface.

Spoken Audio: “Don't rely on hype. Check the evidence class, the human trial record, and the regulatory truth on Therapept.com.”

View Full Spoken Presenter ScriptExpand ▾
PRESENTER: 'Studies show this peptide reverses aging.' You hear it on podcasts every week. Here are four quick questions to cut through the noise. CHECK 1: Who was studied? A rat with a surgically cut tendon is an animal model. It is not human clinical evidence. CHECK 2: Was the study registered? Real human trials are registered on ClinicalTrials.gov before they start. If no registration number exists, treat the claim with extreme skepticism. CHECK 3: Is approved medicine being conflated with research chemicals? Citing a Wegovy clinical trial to sell unregulated research vials is the most common deceptive marketing pattern in the sector. CHECK 4: Does the certificate of analysis verify net weight? A test reporting 99% purity tells you nothing about whether the vial contains 5 milligrams or 1 milligram. CONCLUSION: Evidence has a structure. Look up the real records on Therapept.
View Complete On-Site Educational TranscriptExpand ▾

Evaluating scientific claims in the peptide marketplace requires rigorous distinction between evidence classes. Preclinical animal studies and in vitro cell assays generate mechanistic hypotheses but do not establish clinical efficacy or safety in humans. Furthermore, promotional content frequently cites peer-reviewed clinical trials of approved pharmaceuticals to market unregulated compounded or research chemical analogues.

Short-Form (Vertical 60s): Four tells of a bogus peptide claim in 45 seconds.Topics: media literacy, source tiers, marketing, evidence classes

Planned Episodes in Development (8)

Scheduled for scripting in upcoming production phases.

  • What is lyophilization?

    In Planning

    The white disc at the bottom of the vial used to be a liquid — and the process that dried it is the reason it can sit on a shelf for years.

    Takeaway: Freeze-drying removes water under vacuum without heat; the cake's appearance says nothing about what it contains.

    Runtime: 3-5 min · Short: Why peptides ship as powder, not liquid. 40 seconds.

  • What is bacteriostatic water?

    In Planning

    Two clear bottles, one ingredient apart — and the difference decides how long either stays usable after a needle goes through the stopper.

    Takeaway: Bacteriostatic water is sterile water plus 0.9% benzyl alcohol; the preservative protects the liquid after puncture, not the peptide's chemistry.

    Runtime: 3-5 min · Short: Sterile vs bacteriostatic water in 30 seconds.

  • Understanding concentration math

    In Planning

    Every reconstitution question on the internet is one equation wearing different costumes.

    Takeaway: Concentration = amount ÷ volume; mg, mcg, mL and syringe units convert cleanly once you stop mixing them up.

    Runtime: 3-5 min · Short: One equation, four units, zero magic. 60 seconds.

  • How to read a peptide COA

    In Planning

    This certificate is completely truthful and proves almost nothing. Let me show you why.

    Takeaway: Lot, laboratory and net content carry the document; the percentages are decoration until those three resolve.

    Runtime: 3-5 min · Short: The three fields that matter on a COA. 45 seconds.

  • HPLC vs LC-MS

    In Planning

    One test asks 'how pure is the main peak?' The other asks 'is it even the right molecule?' You want both answers.

    Takeaway: HPLC quantifies the main peak's share of detected area; LC-MS supports identity by mass. Neither answers the other's question.

    Runtime: 3-5 min · Short: Purity vs identity — which test does what. 40 seconds.

  • Human vs animal research

    In Planning

    A rat healed faster. That sentence — and everything it doesn't say — is most of the peptide internet.

    Takeaway: Animal findings generate hypotheses; they do not establish human outcomes, and no conversion formula makes them transferable.

    Runtime: 3-5 min · Short: Why a rat study is a hypothesis, not a promise. 45 seconds.

  • Why peptide studies often disagree

    In Planning

    Two studies, one compound, opposite conclusions — and usually, if you read the methods, they weren't studying the same thing.

    Takeaway: Different salts, doses, routes, durations, endpoints and populations make disagreement the expected outcome, not a scandal.

    Runtime: 3-5 min · Short: Same compound, opposite results — why. 60 seconds.

  • Understanding peptide stacks

    In Planning

    The most-discussed combination in the sector has one honest sentence on its evidence file: nobody has studied the pair.

    Takeaway: A stack is a claim. Evidence for each component is not evidence for the combination — and Therapept labels which kind exists.

    Runtime: 3-5 min · Short: Do stacks work? The honest answer. 45 seconds.